|
AlcaSynn Pharmaceuticals GmbH, Innsbruck, Austria, is a drug development company focussing on the preclinical and clinical development of morphinan opioids.
AlcaSynn is technology leader in the medicinal chemistry of morphinans and disposes of a broad portfolio of innovative drug candidates targeting a variety of different medicinal indications.
AlcaSynn is a subsidiary of Sanochemia Pharmazeutika AG, Vienna (www.sanochemia.at).
 
AlcaSynn is promoted and supported by: |
